Recall Record

Saratoga, CA, United States

Capso Vision, Inc. recalls

3 recalls recorded since 2018, most recently on 26 February 2020. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0

Terminated Class II Medical devices

Recall started
26 February 2020
Terminated
28 January 2021
Reason
Ingestible video capsule system has capsule with incorrect capture mode which will not record data when the capsule is ingested by patients. If used, there is a risk of delay of diagnosis and the patient may need to repeat the exam.
Distribution
US Nationwide distribution including in the states of AZ, CA, DE, MD, NJ, NY, SC, and VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2536-2020

Terminated Class II Medical devices

Recall started
18 October 2019
Terminated
8 January 2021
Reason
Capsule Endoscopy System: a defect present in the capsule window may be stressed through the production process and in the final package, which could cause the housing of the capsule to crack and leak when ingested. Fluid from the patient could leak in to the capsule, which may damage components inside the capsule and the patient data may not be retrieved; the patient may need to repeat the exam.
Distribution
U.S.: CA, TX, FL, VA, PA, SC, HI, DC, NJ, UT, LA. Foreign: FR, AR, IT, UK, BE, TC, AU, CO, GM, GR, SP, SI, HR, MO, SW, EZ.
Initiated
Voluntary: Firm initiated
Recall number
Z-1827-2020

Terminated Class II Medical devices

Recall started
3 July 2019
Terminated
28 January 2021
Reason
Possible mis-labeling of the device with incorrect serial number labels which may result in a patient's misdiagnosis.
Distribution
US Nationwide distribution including in the states of FL, GA, NY, PA, and TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-2073-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.